Measuring masculinity in the context of chronic disease

Chambers, SK; Hyde, MK; Oliffe, JL; Zajdlewicz, L; Lowe, A; Wootten, AC; Dunn, J

Measuring masculinity in the context of chronic disease

Chambers, SK Hyde, MK Oliffe, JL Zajdlewicz, L Lowe, A Wootten, AC Dunn, J

Permalink

Publisher:: EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
Publication Type:: Journal Article
Citation:: Psychology of Men and Masculinity, 2016, 17, (3), pp. 228-242
Issue Date:: 2016-07-01

Closed Access

	Filename	Description	Size
	ContentServer (13).pdf	Published version	757.73 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Chambers, SK
dc.contributor.author	Hyde, MK
dc.contributor.author	Oliffe, JL
dc.contributor.author	Zajdlewicz, L
dc.contributor.author	Lowe, A
dc.contributor.author	Wootten, AC
dc.contributor.author	Dunn, J
dc.date.accessioned	2022-08-03T04:32:52Z
dc.date.available	2022-08-03T04:32:52Z
dc.date.issued	2016-07-01
dc.identifier.citation	Psychology of Men and Masculinity, 2016, 17, (3), pp. 228-242
dc.identifier.issn	1524-9220
dc.identifier.issn	1939-151X
dc.identifier.uri	http://hdl.handle.net/10453/159552
dc.description.abstract	Masculine beliefs are influential in men's responses to illness; however, current measures of masculinity may not be salient for highly prevalent chronic diseases such as prostate cancer. To address this gap, a contextualized measure of masculinity for men with prostate cancer was developed. A novel measure of masculinity, the Masculinity in Chronic Disease Inventory (MCD-I), was developed based on existing qualitative data and tested for acceptability and face validity with 19 men previously treated for prostate cancer. A cross-sectional survey of 403 Australian men with prostate cancer (Mage = 70.34 years; SD = 7.25) then assessed convergent, divergent, and discriminant validity for the MCD-I using existing reliable and valid measures of masculinity, masculine self-esteem, quality of life, erectile dysfunction, and sexual help seeking. A 6-factor structure for the MCD-I (22 items) was confirmed with good to excellent internal reliabilities (alpha = 0.69 -0.92) for the subscale domains of Strength, Sexual Importance/Priority; Family Responsibilities; Emotional Self-Reliance; Optimistic Capacity; and Action Approach. Acceptable convergent and divergent validity was supported, and the MCD-I was also able to discriminate between men with severe versus moderate to mild erectile dysfunction (p = .002) and the Sexual Importance/Priority domain discriminated between men who had sought sexual advice and those who had not (p = .005). A contextual approach to measuring masculinity in men with prostate cancer may help avoid reductionist approaches for focusing on erectile dysfunction in these populations. This also presents a way forward for gender-sensitive psychosocial services and programs for men experiencing prostate cancer.
dc.language	English
dc.publisher	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC
dc.relation.ispartof	Psychology of Men and Masculinity
dc.relation.isbasedon	10.1037/men0000018
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject	1701 Psychology
dc.subject.classification	Social Psychology
dc.title	Measuring masculinity in the context of chronic disease
dc.type	Journal Article
utslib.citation.volume	17
utslib.for	1701 Psychology
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
utslib.copyright.status	closed_access	*
dc.date.updated	2022-08-03T04:32:51Z
pubs.issue	3
pubs.publication-status	Published
pubs.volume	17
utslib.citation.issue	3

Abstract:

Masculine beliefs are influential in men's responses to illness; however, current measures of masculinity may not be salient for highly prevalent chronic diseases such as prostate cancer. To address this gap, a contextualized measure of masculinity for men with prostate cancer was developed. A novel measure of masculinity, the Masculinity in Chronic Disease Inventory (MCD-I), was developed based on existing qualitative data and tested for acceptability and face validity with 19 men previously treated for prostate cancer. A cross-sectional survey of 403 Australian men with prostate cancer (Mage = 70.34 years; SD = 7.25) then assessed convergent, divergent, and discriminant validity for the MCD-I using existing reliable and valid measures of masculinity, masculine self-esteem, quality of life, erectile dysfunction, and sexual help seeking. A 6-factor structure for the MCD-I (22 items) was confirmed with good to excellent internal reliabilities (alpha = 0.69 -0.92) for the subscale domains of Strength, Sexual Importance/Priority; Family Responsibilities; Emotional Self-Reliance; Optimistic Capacity; and Action Approach. Acceptable convergent and divergent validity was supported, and the MCD-I was also able to discriminate between men with severe versus moderate to mild erectile dysfunction (p = .002) and the Sexual Importance/Priority domain discriminated between men who had sought sexual advice and those who had not (p = .005). A contextual approach to measuring masculinity in men with prostate cancer may help avoid reductionist approaches for focusing on erectile dysfunction in these populations. This also presents a way forward for gender-sensitive psychosocial services and programs for men experiencing prostate cancer.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/159552